Table 3.
Participants' characteristics | mRS > 2 | mRS ≤ 2 | P-value |
---|---|---|---|
(N1 = 239) | (N2 = 268) | ||
Age (median, IQR) | 77 (68–83) | 68 (59–75) | <0.01 |
Sex (n, %Male) | 112 (46.8%) | 152 (56.7%) | 0.03 |
Diastolic blood pressure (median, IQR) | 80 (70–90) | 81 (72–90) | 0.71 |
Systolic blood pressure (median, IQR) | 150 (134–171) | 145 (130–162) | 0.02 |
Blood glucose (median, IQR) | 6.6 (5.9–8.1) | 6.4 (5.80–7.55) | 0.07 |
NIHSS (median, IQR) | 17 (12–20) | 10 (6–17) | <0.01 |
Treatment (n, % Intervention) | 86 (35.9%) | 106 (39.5) | 0.40 |
History of atrial fibrillation (n, % Yes) | 88 (36.8%) | 73 (27.2%) | 0.02 |
Diabetes (n, % No) | 192 (80.3%) | 229 (85.4%) | 0.12 |
Hypertension (n, % Yes) | 154 (64.4%) | 148 (55%) | 0.04 |
Creatinine (median, IQR) | 78 (65–96) | 78 (66–91.1) | 0.72 |
International normalized ratio (median, IQR) | 1.02 (1.0–1.10) | 1.0 (1.0–1.10) | 0.09 |
Platelet Count (median, IQR) | 93 (57–142) | 97 (55.8–130.3) | 0.88 |
Hematocrit (median, IQR) | 0.4 (0.37–0.43) | 0.42 (0.39–0.44) | <0.01 |
IQR, Interquartile Range; NIHSS, National Institute of Health Stroke Severity Scale; mRS, Modified Rankin scale.